A manageable condition, with the right care

Why treatment matters

Untreated bleeding does permanent damage

Bleeding into a joint is the characteristic injury. It hurts immediately, and each episode damages the cartilage a little more. Repeated bleeds into the same joint — usually knees, ankles and elbows — cause the arthritis of a much older person, in a teenager. That damage does not reverse.

Bleeding into the brain or an internal organ can kill. Before effective treatment existed, most people with severe hemophilia did not reach adulthood.

With treatment, children go to school and adults go to work. The therapies are not a quality-of-life improvement at the margins; they are the difference between a normal lifespan and a foreshortened, disabled one.

What the treatments are

Three approaches

Clotting factor replacement

The missing protein, infused directly into a vein. It can be given on demand, to stop a bleed that has started, or prophylactically — on a regular schedule, to keep enough factor in the blood that bleeds do not start. Prophylaxis is the standard of care for severe hemophilia, and it is what protects joints over a lifetime.

Non-factor therapies

Newer medicines that work differently, rebalancing the clotting process rather than replacing the missing factor. Emicizumab (brand name Hemlibra) is the best known. Some are given as an injection under the skin rather than into a vein, and less often — which changes daily life considerably. These matter especially for people who have developed an inhibitor, where replacement factor no longer works.

Gene therapy

One-time treatments that give the body the instructions to make its own clotting factor. FDA-approved gene therapies now exist for both hemophilia A and hemophilia B. Approval is not the same as access: they are among the most expensive medicines ever brought to market, only some patients are eligible, and the long-term durability is still being established. Real, and not yet reachable for most people.

How it is given

Mostly at the kitchen table

Most treatment is infused at home rather than in a clinic. The factor arrives as a freeze-dried powder that has to be mixed with sterile liquid, drawn up, and delivered into a vein — and for a family with a young child, that means a parent learning to place an IV in their own son or daughter, two or three times a week, indefinitely. Children often take it over themselves, some as young as seven or eight.

Treatment centers train families to do this, and most manage it well. It is worth understanding, though, what is actually being asked of them: an unremarkable weekday evening, a kitchen table, and a medical procedure.

Home treatment is also why the supply chain matters so much. A delayed shipment or a pharmacy that cannot fill the prescription is not an inconvenience — it is a week without protection.

Where care is coordinated

What comprehensive care means

A Hemophilia Treatment Center is not just a hematologist. It is a team — physicians, nurses, physical therapists, social workers and pharmacists — seeing the same patient in one place, usually once or twice a year for a full review alongside care between visits.

That model exists because these conditions touch everything: joint health, dental work, surgery planning, school, insurance, pregnancy, aging. People treated at an HTC have fewer bleeds, fewer hospitalizations, and live longer than people who are not.

Where to learn more

Other sources

These organizations publish detailed, current, clinically reviewed information:

• CDC — Hemophilia and CDC — von Willebrand disease
• National Bleeding Disorders Foundation, formerly the National Hemophilia Foundation
• Hemophilia Federation of America

For support, programs and help navigating insurance in Texas, start with your member organization: Lone Star Bleeding Disorders Foundation for South Texas, Texas Central Bleeding Disorders for North and Central Texas.